Skip To Main Content
P. Gow on Muck Rack

P. Gow

As seen in: Color Research & Application, Heart, Lung and Circulation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to P. Gow’s profile

Articles by P. Gow

229 Long Term Risk of Stroke in Patients with New Post-Operative Atrial Fibrillation After Liver Transplantation

|
By A. Enayati, A. Koshy, O. Farouque, P. Gow
| Heart, Lung and Circulation Verified
416 The Impact of Coronary Calcium Score as an Addition to Myocardial Perfusion Imaging in Altering Clinical Management (ICCAMPA Trial)
Open in Who Shared Issue with article?

244 Post-Operative Atrial Fibrillation following Liver Transplantation and Association with Adverse Cardiovascular Events

|
By A. Enayati, A. Koshy, A. Teh, P. Gow
| Heart, Lung and Circulation Verified
New postoperative atrial fibrillation (POAF) is common in patients undergoing liver transplantation (LT). However, predictors of POAF following LT and whether it is associated with an increased risk of major adverse cardiac events (MACE) is unclear.
Open in Who Shared Issue with article?

473 Diabetes is an Independent Predictor of Sudden Cardiac Death Following Liver Transplantation: Results From the Australian And New Zealand Liver Transplant Registry Over 30 Years

|
By A. Koshy, P. Gow, R. Jones, H. L. Han
| Heart, Lung and Circulation Verified
Assessment of cause-specific mortality following liver transplantation (LT) has demonstrated a preponderance of sudden cardiac death (SCD). The incidence and predictors of SCD following LT has not been studied.
Open in Who Shared Issue with article?

Rise in Proportional Early Cardiovascular Mortality Following Liver Transplantation: Temporal Trends from the Australian & New Zealand Liver Transplant Registry

|
By M. W. Byrne, A. Koshy, P. Gow, J. Sajeev
| Heart, Lung and Circulation Verified
A Systematic Review and Meta-Analysis on the Incidence of Appropriate Implantable Cardioverter Defibrillator Therapy and Sudden Cardiac Death in Cardiac Sarcoidosis
Open in Who Shared Issue with article?

Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15)

|
By P. A. Thwaites, S. K. Roberts, J. E. Mitchell, S. Mason, G. Jeffrey, J. Aaron George, A. J. Thompson, F. Parker, G. W. McCaughan, S. I. Strasser, B. Morales, P. Gow, A. Wigg, C. Tallis, P. W. Angus
| Color Research & Application Verified
Antiviral therapy for hepatitis C has the potential to improve liver function in patients with decompensated cirrhosis. To examine the virological response and effect of viral clearance in patients with decompensated hepatitis C cirrhosis all with MELD scores ?15 following sofosbuvir/daclatasvir ± ribavirin.
Open in Who Shared Issue with article?
Show More